Real-life use of Doravirine in treatment-experienced people living with HIV: A multicenter Italian study

Use of doravirine (DOR), a new nonnucleoside reverse-transcriptase inhibitors recently approved for HIV treatment, is still unclear in clinical practice and real-life data are scarce. We retrospectively investigated the rationale for switching people with HIV to DOR-containing/-based regimens in a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzitelli, Maria, Antoni, Melania Degli, Castelli, Francesco, Ripamonti, Diego, Zuglian, Gianluca, Lapadula, Giuseppe, Fabbiani, Massimiliano, Ferraresi, Alice, Putaggio, Cristina, Cattelan, Anna Maria, Quiros-Roldan, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333545/
https://www.ncbi.nlm.nih.gov/pubmed/35905209
http://dx.doi.org/10.1097/MD.0000000000029855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333545/
https://www.ncbi.nlm.nih.gov/pubmed/35905209
http://dx.doi.org/10.1097/MD.0000000000029855

Ejemplares similares